Patents Assigned to Singulex, Inc.
-
Publication number: 20130252346Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin, Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: ApplicationFiled: March 12, 2013Publication date: September 26, 2013Applicant: SINGULEX, INC.Inventors: Philippe Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H.B. Wu
-
Patent number: 8535895Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: GrantFiled: November 2, 2012Date of Patent: September 17, 2013Assignees: Singulex, Inc., The Regents of the University of CaliforniaInventors: Philippe Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Allan H. B. Wu
-
Patent number: 8462339Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: GrantFiled: September 10, 2012Date of Patent: June 11, 2013Assignee: Singulex, Inc.Inventor: Richard Livingston
-
Patent number: 8450069Abstract: Cardiovascular disease, e.g., congestive heart failure, is often first diagnosed after the onset of clinical symptoms, eliminating potential for early intervention. The invention provides a multi-marker immunoassay, including cardiac pathology and vascular inflammation biomarkers, yielding a more sensitive assay for early detection of CHF in plasma. A panel consisting of cardiac pathology (cTnI, BNP) and vascular inflammation (IL-6, TNF?, IL-17a) biomarkers provided a sensitivity of 94% for association with CHF.Type: GrantFiled: June 7, 2010Date of Patent: May 28, 2013Assignee: Singulex, Inc.Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard Livingston, Douglas Held, Sara Le
-
Publication number: 20130130403Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: ApplicationFiled: November 2, 2012Publication date: May 23, 2013Applicant: SINGULEX, INC.Inventor: SINGULEX, INC.
-
Publication number: 20130059400Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: ApplicationFiled: September 10, 2012Publication date: March 7, 2013Applicant: SINGULEX, INC.Inventor: Richard A. Livingston
-
Patent number: 8343728Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: GrantFiled: October 12, 2010Date of Patent: January 1, 2013Assignees: Singulex, Inc., The Regents of the University of CaliforniaInventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
-
Patent number: 8264684Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: GrantFiled: February 22, 2011Date of Patent: September 11, 2012Assignee: Singulex, Inc.Inventor: Richard Livingston
-
Publication number: 20110301053Abstract: Disclosed are methods for diagnosing, staging, and predicting risk for developing rheumatoid arthritis and other inflammatory diseases, and methods for identifying treatment responders and non-responders.Type: ApplicationFiled: May 6, 2011Publication date: December 8, 2011Applicant: SINGULEX, INC.Inventors: John Allan Todd, Quynh Anh Thuc Lu, Sara Jane Le
-
Publication number: 20110263043Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: ApplicationFiled: February 22, 2011Publication date: October 27, 2011Applicant: SINGULEX, INC.Inventor: Richard A. Livingston
-
Publication number: 20110111524Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: ApplicationFiled: October 12, 2010Publication date: May 12, 2011Applicant: SINGULEX, INC.Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
-
Patent number: 7914734Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: GrantFiled: December 18, 2008Date of Patent: March 29, 2011Assignee: Singulex, Inc.Inventor: Richard A. Livingston
-
Publication number: 20100329929Abstract: Disclosed are methods, kits, and compositions for the highly sensitive detection of molecules. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomolar, or lower. The methods, kits, and compositions also allow the determination of concentration over a wide range, e.g., 7-log range, without need for sample dilution.Type: ApplicationFiled: March 25, 2010Publication date: December 30, 2010Applicant: SINGULEX, INC.Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held
-
Patent number: 7838250Abstract: The invention provides methods, compositions, kits, and systems for the sensitive detection of cardiac troponin. Such methods, compositions, kits, and systems are useful in diagnosis, prognosis, and determination of methods of treatment in conditions that involve release of cardiac troponin.Type: GrantFiled: April 3, 2008Date of Patent: November 23, 2010Assignees: Singulex, Inc., The Regents of the University of CaliforniaInventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held, Alan Wu
-
Publication number: 20100112727Abstract: The present invention provides single molecule analyses of species of use in analytical, diagnostic or prognostic assays. In exemplary embodiments, the assays utilize samples prepared by novel methods, affording assays of unexpected sensitivity and robustness. The method is described in a non-limiting manner by reference to cytokine assays.Type: ApplicationFiled: September 18, 2009Publication date: May 6, 2010Applicant: Singulex, Inc.Inventors: John Todd, Quynhanh Lu, Robert Freese
-
Patent number: 7572640Abstract: Disclosed are methods, kits, and compositions for the highly sensitive detection of molecules. The methods, kits, and compositions are useful in determining concentrations of molecules in samples to levels of 1 femtomolar, 1 attomolar, or lower. The methods, kits, and compositions also allow the determination of concentration over a wide range, e.g., 7-log range, without need for sample dilution.Type: GrantFiled: April 4, 2007Date of Patent: August 11, 2009Assignee: Singulex, Inc.Inventors: Philippe J. Goix, Robert Puskas, John Todd, Richard A. Livingston, Douglas Held
-
Publication number: 20090159812Abstract: The invention encompasses analyzers and analyzer systems that include a single molecule analyzer, methods of using the analyzer and analyzer systems to analyze samples, either for single molecules or for molecular complexes. The single molecule uses electromagnetic radiation that is translated through the sample to detect the presence or absence of a single molecule. The single molecule analyzer provided herein is useful for diagnostics because the analyzer detects single molecules with zero carryover between samples.Type: ApplicationFiled: December 18, 2008Publication date: June 25, 2009Applicant: SINGULEX, INCInventor: Richard A. Livingston
-
Publication number: 20040166514Abstract: A method for detecting a target nucleic acid molecule or target nucleic acid molecular complex comprising: (a) contacting two or more probes complementary to the molecule or molecular complex, said molecule or molecular complex being labeled with one or more fluorescent dye molecules of the same dye or labeled with two dyes that are indistinguishable by their emission characteristics in an assay instrument, wherein each probe interacts specifically with a different target nucleic acid sequence or a structure on the molecule or molecular complex; and (b) detecting interaction of the probes with the molecule or molecular complex, said interaction being detected by an increase in fluorescence intensity during a detection interval having a fluorescence intensity above the fluorescence intensity of any individual free probe, wherein molecule or molecular complex is analyzed such that only individual molecules or molecular complexes in contact with a probe are within an interrogation volume and within a detection tType: ApplicationFiled: November 19, 2003Publication date: August 26, 2004Applicant: Singulex, Inc.Inventor: Robert Steven Puskas